姓名：江濤   性別：男   職稱：教授

招生類型：科學與專業學位(碩) 科學與專業學位(博)

招生專業：外科學（神外）(碩) 外科學（神外）(博)

研究方向：腦膠質瘤精準醫療

電子信箱：jiangtao369@sohu.com

社會任職

1. 臨床外科雜志副主編

2. 中國醫學科學院學術咨詢委員會學部委員

3. Cancer Biology & Medicine

4. 中國臨床實用醫學副總編輯

5. 中國神經科學學會神經腫瘤分會主任委員

6. 神經疾病與精神衛生雜志主編

7. 首都醫科大學神經外科學院第三屆院務委員會副院長

8. 中國醫師協會腦膠質瘤專業委員會主任委員

9. 全球腦膠質瘤適應性臨床創新試驗體系（GBM AGILE）中方主席

10. 亞洲腦膠質瘤基因組圖譜計劃（AGGA）中方主席

11. Chinese Neurosurgical Journal編委

12. 中華神經外科雜志編委

13. Current Signal Transduction Therapy亞洲區主編

14. Neural Regeneration Research雜志編委

15. 中國藥學會藥物應用分會腫瘤藥物應用學組組長

16. Plos one 雜志學術編輯

17. Chinese Journal of Cancer Research雜志編委

18. 中國微侵襲神經外科學雜志編委

個人簡歷

1. 202208-      :首都醫科大學附屬北京天壇醫院 神經外科中心主任

2. 202208-      :北京市神經外科研究所 所長

3. 2018-      :首都醫科大學神經外科學院 副院長

4. 2013-202208:首都醫科大學附屬北京天壇醫院神經外科中心 副主任

5. 2013-      :北京腦重大疾病研究院腦腫瘤研究所 副所長

6. 2013-202208:北京市神經外科研究所 副所長

7. 2013-      :北京市神經外科研究所 神經分子病理室 主任

8. 200805-      :首都醫科大學腫瘤學系 副主任

9. 200407-      :首都醫科大學附屬北京天壇醫院 主任醫師

10. 200407-      :首都醫科大學附屬北京市神經外科研究所 分子神經病理室 副主任

11. 200202-200402:MD Anderson Cancer Center（USA） 訪問學者

12. 199809-200202:首都醫科大學附屬北京天壇醫院 副主任醫師

13. 199609-199807:北京市神經外科研究所 博士后工作

14. 199109-199607:哈爾濱醫科大學 研究生學習（碩博連讀）

重要學術論文

1. Fang S, Li L, Weng S, Guo Y, Zhang Z, Wang L, Fan X, Wang Y, Jiang T. .Decreasing Shortest Path Length of the Sensorimotor Network Induces Frontal Glioma-Related Epilepsy..Front Oncol..2022.12.840871.SCI

2. Ma, W., Bao, Z., Qian, Z., Zhang, K., Fan, W., Xu, J., Ren, C., Zhang, Y., & Jiang, T..LRRFIP1, an epigenetically regulated gene, is a prognostic biomarker and predicts malignant phenotypes of glioma.CNS neuroscience & therapeutics,.2022.28(6).873–883..SCI

3. Chai, R., Fang, S., Pang, B., Liu, Y., Wang, Y., Zhang, W., & Jiang, T..Molecular pathology and clinical implications of diffuse glioma.Chinese medical journal.2022.135(24).2914–2925.SCI

4. Wu, L., Chai, R., Zhao, Z., Wang, Q., & Jiang, T.Role of the tumor microenvironment in shaping IDH-wildtype glioma plasticity, and potential therapeutic strategies.. Cancer biology & medicine.2022. 19(10).1423–1427.SCI

5. Chai, R. C., Liu, X., Pang, B., Liu, Y. Q., Li, J. J., Li, Y. F., Zhao, Z., Du, J., Bao, Z. S., & Jiang, T. .Recurrent PTPRZ1-MET fusion and a high occurrence rate of MET exon 14 skipping in brain metastases.Cancer science.2022.113(2).796–801..SCI

6. Zhao, Z., Zhang, K. N., Sun, Z., Yang, C., Wang, Q., Li, G., Wang, Z., Zeng, F., Chai, R., Qian, Z., Wang, Z., Liu, Y., Ma, W., Wu, F., & Jiang, T.WES data from 286 diffuse gliomas under the 2021 WHO Classification of Tumors of the Central Nervous System.Scientific data.2022.9(1).692.SCI

7. Li, L., Zhang, C., Wang, Z., Guo, Y., Wang, Y., Fan, X., & Jiang, T..Expression changes in ion channel and immunity genes are associated with glioma-related epilepsy in patients with diffuse gliomas.Journal of cancer research and clinical oncology.2022.148(10).2793–2802..SCI

8. Fang, S., Li, L., Weng, S., Guo, Y., Zhong, Z., Fan, X., Jiang, T., & Wang, Y..Contralesional Sensorimotor Network Participates in Motor Functional Compensation in Glioma Patients.Frontiers in oncology.2022.12.882313.SCI

9. Fang, S., Li, L., Weng, S., Zhang, Z., Fan, X., Jiang, T., & Wang, Y..Increasing nodal vulnerability and nodal efficiency implied recovery time prolonging in patients with supplementary motor area syndrome.Human brain mapping.2022.43(13).3958–3969..SCI

10. Fan, W., Wang, D., Li, G., Xu, J., Ren, C., Sun, Z., Wang, Z., Ma, W., Zhao, Z., Bao, Z., Jiang, T., & Zhang, Y..A novel chemokine-based signature for prediction of prognosis and therapeutic response in glioma.CNS neuroscience & therapeutics,.2022.28(12),.2090–2103..SCI

11. Wu, L., Wu, W., Zhang, J., Zhao, Z., Li, L., Zhu, M., Wu, M., Wu, F., Zhou, F., Du, Y., Chai, R. C., Zhang, W., Qiu, X., Liu, Q., Wang, Z., Li, J., Li, K., Chen, A., Jiang, Y., Xiao, X., … Wang, Q.Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma.. Cancer discovery.2022. 12(12).2820–2837.SCI

12. 劉幸 楊靜塵 王引言 張偉 杜江 崔云 李桂林 江濤.拉曼光譜分析技術在腦膠質瘤術中病理學診斷中的應用.中華神經外科雜志.2022.38（008）. .核心期刊

13. Ruoyu Huang , Yanwei Liu , Kuanyu Wang, Zheng Wang , Chuanbao Zhang , Wei Zhang , Zheng Zhao , Guanzhang Li , Lijie Huang , Yuanhao Chang , Fan Zeng , Tao Jiang , Huimin Hu .High-sensitive clinical diagnostic method for PTPRZ1-MET and the characteristic protein structure contributing to ligand-independent MET activation.CNS Neurosci Ther.2021.27(5).617-628.SCI

14. Shengyu Fang,Yinyan Wang,Tao Jiang .Epilepsy enhance global efficiency of language networks in right temporal lobe gliomas.CNS Neurosci Ther.2021.27(3).363-371.SCI

15. Shengyu Fang,Chunyao Zhou,Yinyan Wang,Tao Jiang *.Contralesional functional network reorganization of the insular cortex in diffuse low-grade glioma patients.Scientific Reports.2021.11(1),.623.SCI

16. Pei Yang , Kuanyu Wang, Chuanbao Zhang , Zhiliang Wang , Qi Liu , Jiangfei Wang , Tao Jiang*, Xia Shan*.Novel roles of VAT1 expression in the immunosuppressive action of diffuse gliomas.Cancer Immunol Immunother.2021.70(9),.2589-2600.SCI

17. Ruoyu Huang , Guanzhang Li , Kuanyu Wang, Zhiliang Wang, Fan Zeng, Huimin Hu , Tao Jiang*.Comprehensive Analysis of the Clinical and Biological Significances of Endoplasmic Reticulum Stress in Diffuse Gliomas". Frontiers in Cell and Developmental Biology.2021.9(619).396.SCI

18. Ying Zhang , Wenping Ma, Wenhua Fan , Changyuan Ren , Jianbao Xu , Fan Zeng , Zhaoshi Bao, Tao Jiang *, Zheng Zhao*.Comprehensive transcriptomic characterization reveals core genes and module associated with immunological changes via 1619 samples of brain glioma".Cell Death and Disease.2021.12(12),.1140.SCI

19. Ruichao Chai, Guanzhang Li , Yuqing Liu , Kenan Zhang , Zheng Zhao , Fan Wu , Yuzhou Chang , Bo Pang , Jingjun Li , Yangfang Li , Tao Jiang , Yongzhi Wang.Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma.Cancer Biol Med.2021.18(1),.272-282.SCI

20. Zheng Zhao, Ke-Nan Zhang, Qiangwei Wang , Guanzhang Li , Fan Zeng , Ying Zhang , Fan Wu , Ruichao Chai , Zheng Wang , Chuanbao Zhang , Wei Zhang , Zhaoshi Bao, Tao Jiang .Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Gliomas.Genomics Proteomics Bioinformatics.2021.19(1),.1-12.SCI

21. Rui-Chao Chai , Yu-Zhou Chang, Xin Chang, Bo Pang, Song Yuan An, Ke-Nan Zhang, Yuan-Hao Chang, Tao Jiang*, Yong-Zhi Wang*."YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3?mediated m6A modification to activate NF?κB and promote the malignant progression of glioma".Journal of Hematology&Oncology.2021.14,.109.SCI

22. Wei Zhang , You Zhai, Guanzhang Li, Tao Jiang.A novel gene signature based on five immune checkpoint genes predicts the survival of glioma.Chin Neurosurg J.2021.7(1).15.SCI

23. Shengyu Fang, Chunyao Zhou , Lei Wang , Xing Fan, Yinyan Wang, Zhong Zhang, Tao Jiang*.Characteristic Alterations of Network in Patients With Intraoperative Stimulation-Induced Seizures During Awake Craniotomy.Frontiers in Neurology.2021.12(602).716.SCI

24. Lianwang Li , Guanzhang Li , Shengyu Fang , Kenan Zhang, Ruoyu Huang , Yinyan Wang, Chuanbao Zhang , Yiming Li , Wei Zhang , Zhong Zhang , Qiang Jin , Dabiao Zhou , Xing Fan , Tao Jiang .New-Onset Postoperative Seizures in Patients With Diffuse Gliomas: A Risk Assessment Analysis".Frontiers in Neurology.2021.12(682).535.SCI

25. Shengyu Fang, Yuchao Liang, Lianwang Li, Lei Wang, Xing Fan, Yinyan Wang, Tao Jiang.Tumor location?based classification of surgery?related language impairments in patients with glioma".Journalof Neuro-Oncology.2021.155(2),.143-152.SCI

26. Liu, H J; Hu, H M; Li, G Z; Zhang, Y; Wu, F; Liu, X; Wang, K Y; Zhang, C B; Jiang, T*.Ferroptosis-Related Gene Signature Predicts Glioma Cell Death and Glioma Patient Progression.Frontiers in Cell and Developmental Biology.2020.8（2296-634X）.538.SCI

27. Wu, C; Song, H#; Fu, X; Li, S; Jiang, T*.Transcriptomic Analysis of Glioma Based on IDH Status Identifies ACAA2 as a Prognostic Factor in Lower Grade Glioma.Biomed Research International.2020.2020.1086792.SCI

28. Zhou, K; Zhao, Z; Li, S; Liu, Y; Li, G; Jiang, T*.A new glioma grading model based on histopathology and Bone Morphogenetic Protein 2 mRNA expression.Scientific Reports.2020.10（1）.18420.SCI

29. Yu, Kai; Hu, Yuqiong; Wu, Fan; Guo, Qiufang; Qian, Zenghui; Hu, Waner; Chen, Jing; Wang, Kuanyu; Fan, Xiaoying; Jiang, Tao*;Wu, Xinglong*.Surveying brain tumor heterogeneity by single-cell RNA-sequencing of multi-sector biopsies_1.National Science Review.2020.7(8).1306–1318.SCI

30. Zhou, K; Liu, Y; Zhao, Z; Wang, Y; Huang, L; Chai, R; Li, G; Jiang, T*.ABCC8 mRNA expression is an independent prognostic factor for glioma and can predict chemosensitivity.Scientific Reports.2020.10（1）.12682.SCI

31. Li, G; Zhai, Y; Liu, H; Wang, Z; Huang, R; Jiang, H; Feng, Y; Chang, Y; Wu, F; Zeng, F; Jiang, T*; Zhang, W*.RPP30, a transcriptional regulator, is a potential pathogenic factor in glioblastoma..Aging.2020.12（16）.16155-16171.SCI

32. Huang, L; Wang, Z; Chang, Y; Wang, K; Kang, X; Huang, R; Zhang, Y; Chen, J; Zeng, F; Wu, F; Zhao, Z; Li, G; Huang, H; Jiang, T*; Hu, H*.EFEMP2 indicates assembly of M0 macrophage and more malignant phenotypes of glioma.Aging-US.2020.12（9）.8397-8412.SCI

33. Li, G; Zhai, Y; Wang, Z; Wang, Z; Huang, R; Jiang, H; Li, R; Feng, Y; Chang, Y; Jiang, T*；Zhang, W*.Postoperative standard chemoradiotherapy benefits primary glioblastoma patients of all ages.Cancer Med.2020.9(6).1-11.SCI

34. Yu-Qing Liu#, Rui-Chao Chai#, Yong-Zhi Wang, Zheng Wang, Xing Liu, Fan Wu*, Tao Jiang*.Amino acid metabolism-related gene expression-based risk signature can better predict overall survival for glioma.Cancer Science.2019.110(1).321-333.SCI

35. Chong Qi#, Yiming Li#, Xing Fan, Yin Jiang, Rui Wang, Song Yang, Lanxi Meng, Tao Jiang*, Shaowu Li*.A quantitative SVM approach potentially improves the accuracy of magnetic resonance spectroscopy in the preoperative evaluation of the grades of diffuse gliomas.NeuroImage: Clinical.2019.23(101835).1-7.SCI

36. 國家衛生健康委員會醫政醫管局，江濤*.腦膠質瘤診療規范（2018 年版）.中華神經外科雜志.2019.35(3).217-239.核心期刊

37. Zheng Zhao#, Ke-Nan Zhang#, Rui-Chao Chai#, Kuan-Yu Wang#, Ruo-Yu Huang, Guan-Zhang Li, Yong-Zhi Wang, Jing Chen*, Tao Jiang*.ADAMTSL4, a Secreted Glycoprotein, Is a Novel Immune-Related Biomarker for Primary Glioblastoma Multiforme.Disease Markers.2019.2019(0).1802620.SCI

38. Zhi-Liang Wang#, Zheng Wang, Guan-Zhang Li, Qiang-Wei Wang, Zhao-Shi Bao, Chuan-Bao Zhang*, Tao Jiang*.Immune Cytolytic Activity Is Associated With Genetic and ClinicalProperties of Glioma.Frontiers in Immunology.2019.8(10).1756.SCI

39. Fan Wu#, Zheng Zhao#, Rui-Chao Chai#, Yu-Qing Liu, Guan-Zhang Li, Hao-Yu Jiang, Tao Jiang*.Prognostic power of a lipid metabolism gene panel for diffuse gliomas.JOURNAL OF CELLULAR AND MOLECULAR MEDICINE.2019.23(11).7741-7748.SCI

40. Zhi-Liang Wang#, Chuan-Bao Zhang, Yu-Qing Liu, Zheng Wang*, Tao Jiang*.Peripheral blood test provides a practical method for glioma evaluation and prognosis prediction.CNS Neurosci Ther.2019.8(8).876-883.SCI

41. Zhi-Liang Wang#, Zheng Zhao, Zheng Wang*, Chuan-Bao Zhang*, Tao Jiang*.Predicting chromosome 1p/19q codeletion by RNA expression profile: a comparison of current prediction models.Aging-US.2019.11(3).974-985.SCI

42. Zhi-Liang Wang#, Guan-Zhang Li, Qiang-Wei Wang, Zhao-Shi Bao, Zheng Wang*, Chuan-Bao Zhang*, Tao Jiang*.PD-L2 expression is correlated with the molecular and clinical features of glioma, and acts as an unfavorable prognostic factor.ONCOIMMUNOLOGY.2019.11(8).e1541535-2.SCI

43. Shuli Liang#, Xing Fan#, Ming Zhao, Xia Shan, Wenling Li, Ping Ding, Gan You, Zhen Hong, Xuejun Yang, Guoming Luan, Wenbin Ma, Hui Yang, Yongpin You, Tianming Yang, Liang Li, Weiping Liao, Lei Wang, Xun Wu, Xinguang Yu, Jianguo Zhang, Qing Mao, Yuping Wang, Wenbin Li, Xuefeng Wang, Chuanlu Jiang, Xi.Clinical practice guidelines for the diagnosis and treatment of adult diffuse glioma-related epilepsy.Cancer medicine.2019.8(10).4527-4535.SCI

44. Guan-Zhang Li #, Ke-Nan Zhang #, Zheng Wang, Hui-Min Hu, Zhi-Liang Wang, Ruo-Yu Huang, Hao-Yu Jiang, You Zhai, Yue-Mei Feng, Yuan-Hao Chang, Ren-Peng Li, Fan Wu, Fan Zeng, Tao Jiang*, Wei Zhang*.Siglecs, Novel Immunotherapy Targets, Potentially Enhance The Effectiveness of Existing Immune Checkpoint Inhibitors in Glioma Immunotherapy.OncoTargets and Therapy.2019.0(12).10263–10273.SCI

45. Rui-Chao Chai#, Ke-Nan Zhang, Yu-Zhou Chang, Fan Wu, Yu-Qing Liu, Zheng Zhao, Kuan-Yu Wang, Yuan-Hao Chang, Tao Jiang*, Yong-Zhi Wang*.Systematically characterize the clinical and biological significances of 1p19q genes in 1p/19q non-codeletion glioma.Carcinogenesis.2019.40(10).1229-1239.SCI

46. Kai Huang#, Xing Liu#, Yansheng Li#, Qixue Wang, Junhu Zhou, Yunfei Wang, Feng Dong, Chao Yang, Zhiyan Sun, Chuan Fang, Chaoyong Liu, Yanli Tan, Xudong Wu*, Tao Jiang*, Chunsheng Kang*.Genome-Wide CRISPR-Cas9 Screening Identifies NF-κB/E2F6 Responsible for EGFRvIII-Associated Temozolomide Resistance in Glioblastoma.advanced science.2019.2019(6).1900782 (1 of 16).SCI

47. L. Jingshan, F. Shengyu, F. Xing, W. Zheng, Z. Chuanbao, Q. Zenghui, L. Xing, S. Lihua, L. Guanzhang, Y. Fuqiang, J. Shuai, W. Yinyan, and J. Tao*.Morphometry of the Hand Knob Region and Motor Function Change in Eloquent Area Glioma Patients.Clin Neuroradiol.2018. . .SCI

48. Z. Wang, X. Liu, Z. Wang, Z. Bao, W. Zhang, C. Zhang, and T. Jiang*.Identification of a Good-Prognosis IDH-Mutant-Like Population of Patients with Diffuse Gliomas.Curr Mol Med.2018.17(7): .518-526..SCI

49. X. Ding#, Z. Wang#, D. Chen#, Y. Wang#, Z. Zhao, C. Sun, D. Chen, C. Tang, J. Xiong, L. Chen, Z. Yao, Y. Liu, X. Wang, D. P. Cahill, J. F. de Groot*, T. Jiang*, Y. Yao*, and L. Zhou. .The prognostic value of maximal surgical resection is attenuated in oligodendroglioma subgroups of adult diffuse glioma: a multicenter retrospective study.J Neurooncol..2018.140(3).591-603.SCI

50. Hu H#, Mu Q#, Bao Z#, Chen Y#, Liu Y#, Chen J, Wang K, Wang Z, Nam Y, Jiang B, Sa JK, Cho HJ, Her NG, Zhang C, Zhao Z, Zhang Y, Zeng F, Wu F, Kang X, Liu Y, Qian Z, Wang Z, Huang R, Wang Q, Zhang W, Qiu X, Li W, Nam DH, Fan X*, Wang J*, Jiang T*.Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor.Cell.2018.175(6).1665-1678.SCI

51. G. Li#, Y. Li#, X. Liu, Z. Wang, C. Zhang, F. Wu, H. Jiang, W. Zhang, Z. Bao, Y. Wang, J. Cai, L. Zhao, U. D. Kahlert, T. Jiang*, and W. Zhang*.ALDH1A3 induces mesenchymal differentiation and serves as a predictor for survival in glioblastoma.Cell Death Dis..2018.9(12).1190.SCI

52. G. Li#, Z. Wang#, C. Zhang, X. Liu, F. Yang, L. Sun, J. Liang, H. Hu, Y. Liu, G. You, Z. Bao, W. Zhang, Z. Wang*, and T. Jiang*..MEGF10, a Glioma Survival-Associated Molecular Signature, Predicts IDH Mutation Status.Dis Markers.2018.2018.5975216.SCI

53. Y. Li#, X. Liu#, K. Xu, Z. Qian, K. Wang, X. Fan, S. Li, Y. Wang*, and T. Jiang*. .MRI features can predict EGFR expression in lower grade gliomas: A voxel-based radiomic analysis.Eur Radiol.2018.28(1).356-362.SCI

54. S. Liu, X. Fan, C. Zhang, Z. Wang, S. Li, Y. Wang, X. Qiu*, and T. Jiang*.MR imaging based fractal analysis for differentiating primary CNS lymphoma and glioblastoma.Eur Radiol.2018.29(3).1348-1354.SCI

55. Y. Li#, X. Liu#, Z. Qian, Z. Sun, K. Xu, K. Wang, X. Fan, Z. Zhang, S. Li, Y. Wang*, and T. Jiang*..Genotype prediction of ATRX mutation in lower-grade gliomas using an MRI radiomics signature.Eur Radiol.2018.28(7).2960-2968.SCI

56. S. Liu#, Z. Wang#, Y. Wang, X. Fan, C. Zhang, W. Ma, X. Qiu#, and T. Jiang#. .PD-1 related transcriptome profile and clinical outcome in diffuse gliomas.Oncoimmunology.2018.7(2).e1382792.SCI

57. X. Liu#, Y. Li#, Z. Qian, Z. Sun, K. Xu, K. Wang, S. Liu, X. Fan, S. Li, Z. Zhang, T. Jiang*, and Y. Wang*..A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomas.Neuroimage Clin..2018.20.1070-1077.SCI

58. X. Liu#, Y. Li#, Z. Sun, S. Li, K. Wang, X. Fan, Y. Liu, L. Wang, Y. Wang*, and T. Jiang*. .Molecular profiles of tumor contrast enhancement: A radiogenomic analysis in anaplastic gliomas..Cancer Med..2018.7(9).4273-4283.SCI

59. Z. Liu#, Y. Wang#, X. Liu#, Y. Du, Z. Tang, K. Wang, J. Wei, D. Dong, Y. Zang, J. Dai, T. Jiang*, and J. Tian*.Radiomics analysis allows for precise prediction of epilepsy in patients with low-grade gliomas..Neuroimage Clin..2018.17.271-278.SCI

60. Z. Qian, Y. Li, X. Fan, C. Zhang, Y. Wang*, T. Jiang*, and X. Liu*..Prognostic value of a microRNA signature as a novel biomarker in patients with lower-grade gliomas..J Neurooncol.2018.137(1).127-137.SCI

61. Z. Qian#, Y. Li#, Z. Sun, X. Fan, K. Xu, K. Wang, S. Li, Z. Zhang, T. Jiang*, X. Liu*, and Y. Wang*. .Radiogenomics of lower-grade gliomas: a radiomic signature as a biological surrogate for survival prediction.Aging (Albany NY)..2018.10(10).2884-2899.SCI

62. Y. Li#, X. Liu#, K. Xu, Z. Qian, K. Wang, X. Fan, S. Li, Y. Wang*, and T. Jiang*. .MRI features can predict EGFR expression in lower grade gliomas: A voxel-based radiomic analysis.Eur Radiol.2018.28(1).356-362.SCI

63. Y. Li, Z. Qian, K. Xu, K. Wang, X. Fan, S. Li, T. Jiang*, X. Liu*, and Y. Wang*..MRI features predict p53 status in lower-grade gliomas via a machine-learning approach.Neuroimage Clin.2018.17.306-311.SCI

64. K. Wang#, R. Huang#, G. Li, F. Zeng, Z. Zhao, Y. Liu, H. Hu*, and T. Jiang*.CKAP2 expression is associated with glioma tumor growth and acts as a prognostic factor in highgrade glioma.Oncol Rep.2018.40(4).2036-2046.SCI

65. K. Wang#, Y. Wang#, X. Fan, Y. Li, X. Liu, J. Wang, L. Ai, J. Dai, and T. Jiang*.Regional specificity of 1p/19q co-deletion combined with radiological features for predicting the survival outcomes of anaplastic oligodendroglial tumor patients.J Neurooncol..2018.136(3).523-531.SCI

66. Q. Wang#, Z. Wang#, G. Li, C. Zhang, Z. Bao, Z. Wang*, G. You*, and T. Jiang*. .Identification of IDH-mutant gliomas by a prognostic signature according to gene expression profiling.Aging (Albany NY).2018.10(8).1977-1988.SCI

67. Z. Wang, X. Liu, Z. Wang, Z. Bao, W. Zhang, C. Zhang*, and T. Jiang*.Identification of a Good-Prognosis IDH-Mutant-Like Population of Patients with Diffuse Gliomas..Curr Mol Med..2018.17(7).518-526.SCI

68. Z. Qian, Y. Li, X. Fan, C. Zhang, Y. Wang, T. Jiang*, and X. Liu..Molecular and clinical characterization of IDH associated immune signature in lower-grade gliomas..Oncoimmunology.2018.7(6).e1434466.SCI

69. Z. Wang, Y. Hao, C. Zhang, Z. Wang, X. Liu, G. Li, L. Sun, J. Liang, J. Luo, D. Zhou, R. Chen, and T. Jiang*.The Landscape of Viral Expression Reveals Clinically Relevant Viruses with Potential Capability of Promoting Malignancy in Lower-Grade Glioma.Clin Cancer Res.2017.23(9): .2177-2185..SCI

70. C. Qi, S. Yang, L. Meng, H. Chen, Z. Li, S. Wang, T. Jiang*, and S. Li..Evaluation of cerebral glioma using 3T diffusion kurtosis tensor imaging and the relationship between diffusion kurtosis metrics and tumor cellularity.J Int Med Res.2017.45（4）.1347-1358.SCI

71. H. Hu, Z. Wang, M. Li, F. Zeng, K. Wang, R. Huang, H. Wang, F. Yang, T. Liang, H. Huang, and T. Jiang*.Gene Expression and Methylation Analyses Suggest DCTD as a Prognostic Factor in Malignant Glioma.Sci Rep.2017.7(1).11568.

72. S. Fang, J. Liang, T. Qian, Y. Wang, X. Liu, X. Fan, S. Li, Y. Wang, and T. Jiang*..Anatomic Location of Tumor Predicts the Accuracy of Motor Function Localization in Diffuse Lower-Grade Gliomas Involving the Hand Knob Area.AJNR Am J Neuroradiol,.2017.38(10).1990-1997.SCI

73. Y. Li, X. Liu, K. Xu, Z. Qian, K. Wang, X. Fan, S. Li, Y. Wang, and T. Jiang*.MRI features can predict EGFR expression in lower grade gliomas: A voxel-based radiomic analysis.Eur Radiol.2017. . .

74. Y. Li, Z. Qian, K. Xu, K. Wang, X. Fan, S. Li, X. Liu, Y. Wang, and T. Jiang*. Radiomic features predict Ki-67 expression level and survival in lower grade gliomas.J Neurooncol.2017. . .SCI

75. X. Shan, X. Fan, X. Liu, Z. Zhao, Y. Wang, and T. Jiang*.Clinical characteristics associated with postoperative seizure control in adult low-grade gliomas: a systematic review and meta-analysis.Neuro Oncol.2017. . .SCI

76. L. H. Sun, F. Q. Yang, C. B. Zhang, Y. P. Wu, J. S. Liang, S. Jin, Z. Wang, H. J. Wang, Z. S. Bao, Z. X. Yang, and T. Jiang*.Overexpression of Paxillin Correlates with Tumor Progression and Predicts Poor Survival in Glioblastoma. CNS Neurosci Ther.2017.23(1): .69-75.SCI

77. Y. Wang, Y. Wang, X. Fan, S. Li, X. Liu, J. Wang, and T. Jiang*.Putamen involvement and survival outcomes in patients with insular low-grade gliomas. J Neurosurg.2017.126(6).1788-1794.SCI

78. Z. Zhao, F. Meng, W. Wang, Z. Wang, C. Zhang, and T. Jiang*.Comprehensive RNA-seq transcriptomic profiling in the malignant progression of gliomas.Sci Data.2017.4(170024.. .SCI

79. F. Yang, X. Liu, Y. Liu, Y. Liu, C. Zhang, Z. Wang, T. Jiang*, and Y. Wang.miR-181d/MALT1 regulatory axis attenuates mesenchymal phenotype through NF-kappaB pathways in glioblastoma. Cancer Lett.2017.396(1）. .SCI

80. F. Wu, C. Zhang, J. Cai, F. Yang, T. Liang, X. Yan, H. Wang, W. Wang, J. Chen, and T. Jiang*.Upregulation of long noncoding RNA HOXA-AS3 promotes tumor progression and predicts poor prognosis in glioma.Oncotarget.2017. 8(32):. 53110-53123.SCI

81. J Cai, P Zhu, C Zhang, Q Li, Z Wang, G Li, G Wang, P Yang, J Li, B Han, C Jiang*, Y Sun*, and T Jiang*.Detection of ATRX and IDH1-R132H immunohistochemistry in the progression of 211 paired gliomas.Oncotarget.2016.7（13）.16384-16395.SCI

82. X Fan, Y Wang, K Wang, S Liu, Y Liu, J Ma, S Li, and T Jiang.Anatomical specificity of vascular endothelial growth factor expression in glioblastomas: a voxel-based mapping analysis. Neuroradiology.2016.58(1).69-75.SCI

83. X Fan, Y Wang, C Zhang, X Liu, Z Qian, and T Jiang*. Human leukocyte antigen-G overexpression predicts poor clinical outcomes in low-grade gliomas.J Neuroimmunol.2016. 294.27-31.SCI

84. S Liu, Y Wang, X Fan, J Ma, W Ma, R Wang, and T Jiang.Anatomical Involvement of the Subventricular Zone Predicts Poor Survival Outcome in Low-Grade Astrocytomas. PLoS One.2016.11(4).e0154539.SCI

85. K Wang, Y Wang, X Fan, J Wang, G Li, J Ma, J Ma, T Jiang*, and J Dai*.Radiological features combined with IDH1 status for predicting the survival outcome of glioblastoma patients.Neuro Oncol.2016.18(4).589-97.SCI

86. T Jiang, Y Mao, W Ma, Q Mao, Y You, X Yang, C Jiang, C Kang, X Li, L Chen, X Qiu, W Wang, W Li, Y Yao, S Li, S Li, A Wu, K Sai, H Bai, G Li, B Chen, K Yao, X Wei, X Liu, Z Zhang, Y Dai, S Lv, L Wang, Z Lin, J Dong, G Xu, X Ma, J Cai, W Zhang, H Wang, L Chen, C Zhang, P Yang, W Yan, Z Liu, H Hu, J.CGCG clinical practice guidelines for the management of adult diffuse gliomas.Cancer Lett.2016.375(2).263-73.SCI

87. M Y Li, P Yang, Y W Liu, C B Zhang, K Y Wang, Y Y Wang, K Yao, W Zhang, X G Qiu, W B Li, X X Peng, Y Z Wang, and T Jiang*.Low c-Met expression levels are prognostic for and predict the benefits of temozolomide chemotherapy in malignant gliomas.Sci Rep.2016.6.21141.SCI

88. Y Liu, H Hu, C Zhang, Z Wang, M Li, and T Jiang*. Integrated analysis identified genes associated with a favorable prognosis in oligodendrogliomas. Genes Chromosomes Cancer.2016.55(2).169-76.SCI

89. Y Wang, K Wang, J Wang, S Li, J Ma, J Dai, and T Jiang*.Identifying the association between contrast enhancement pattern, surgical resection, and prognosis in anaplastic glioma patients.Neuroradiology.2016.58(4). 367-74.SCI

90. P Yang, J Cai, W Yan, W Zhang, Y Wang, B Chen, G Li, S Li, C Wu, K Yao, W Li, X Peng, Y You, L Chen, C Jiang, X Qiu, T Jiang*, and C project.Classification based on mutations of TERT promoter and IDH characterizes subtypes in grade IIIII gliomas.Neuro Oncol.2016.18(8).1099-1108.SCI

91. Z Wang, C Zhang, L Sun, J Liang, X Liu, G Li, K Yao, W Zhang, and T Jiang*.FGFR3, as a receptor tyrosine kinase, is associated with differentiated biological functions and improved survival of glioma patients.Oncotarget.2016.7（51）.84587-84593.SCI

92. Z Wang, C Zhang, X Liu, Z Wang, L Sun, G Li, J Liang, H Hu, Y Liu, W Zhang, and T Jiang*.Molecular and clinical characterization of PD-L1 expression at transcriptional level via 976 samples of brain glioma.Oncoimmunology.2016. e1196310. .SCI

93. S Fang, Y Wang, and T Jiang*.The Influence of Frontal Lobe Tumors and Surgical Treatment on Advanced Cognitive Functions. .World Neurosurg.2016.91.340-346.SCI

94. P Yang, T Liang, C Zhang, J Cai, W Zhang, B Chen, X Qiu, K Yao, G Li, H Wang, C Jiang, G You, and T Jiang*.Clinicopathological factors predictive of postoperative seizures in patients with gliomas.Seizure.2016.35(2016).93-99.SCI

95. Yang, P#. Zhang, W#. Wang, Y. Peng, X. Chen, B. Qiu, X. Li, G. Li, S. Wu, C. Yao, K. Li, W. Yan, W. Li, J. You, Y. Chen, C. C. Jiang, T*.IDH mutation and MGMT promoter methylation in glioblastoma results of a prospective registry.Oncotarget.2016.6(38).40896-40906.SCI

96. X Fan, Y Wang, Y Liu, X Liu, C Zhang, L Wang, S Li, J Ma, and T Jiang*.Brain regions associated with telomerase reverse transcriptase promoter mutations in primary glioblastomas.J Neurooncol.2016.128(3).455-462..SCI

97. Wang K, Wang YY, Wang JF, Ma J, Jiang T*, Dai JP..Radiologic Features and Expression of Vascular Endothelial Growth Factor Stratify Survival Outcomes in Patients with Glioblastoma.AJNR Am J Neuroradiol.2016.37（2016）.629-935.SCI

98. J Cai, J Chen, W Zhang, P Yang, C Zhang, M Li, K Yao, H Wang, Q Li, C Jiang*, and T Jiang*.Loss of ATRX, associated with DNA methylation pattern of chromosome end, impacted biological behaviors of astrocytic tumors.Oncotarget.2015.6(20).18105-15.SCI

99. H Hu, Z Wang, Y Liu, C Zhang, M Li, W Zhang, K Wang, J Cai, W Cheng, H Huang, and T Jiang.Genome-wide transcriptional analyses of Chinese patients reveal cell migration is attenuated in IDH1-mutant glioblastomas. Cancer Lett.2015.357(2). 566-74.SCI

100. M Y Li, Y Y Wang, J Q Cai, C B Zhang, K Y Wang, W Cheng, Y W Liu, W Zhang, and T Jiang*.Isocitrate dehydrogenase 1 Gene Mutation Is Associated with Prognosis in Clinical Low-Grade Gliomas.PLoS One.2015.10(6).e0130872.SCI

101. Y Liu, H Hu, C Zhang, Z Wang, M Li, W Zhang, and T Jiang*. Methylation associated genes contribute to the favorable prognosis of gliomas with mutation. Am J Cancer Res.2015.5(9). 2745-2755.SCI

102. H Wang, T Tao, W Yan, Y Feng, Y Wang, J Cai, Y You*, T Jiang*, and C Jiang*.Upregulation of miR-181s reverses mesenchymal transition by targeting KPNA4 in glioblastoma.Sci Rep, .2015.5.13072.SCI

103. Y Wang, X Fan, W Zhang, C Zhang, J Wang, T Jiang*, and L Wang*.Deficiency of very large G-protein-coupled receptor-1 is a risk factor of tumor-related epilepsy: a whole transcriptome sequencing analysis.J Neurooncol.2015.121(3). 609-16.SCI

104. Y Liu, H Hu, C Zhang, H Wang, W Zhang, Z Wang, M Li, W Zhang, D Zhou*, and T Jiang*.Co-expression of mitosis-regulating genes contributes to malignant progression and prognosis in oligodendrogliomas.Oncotarget.2015.6(35).38257-69.SCI

105. Y Wang, S Liu, X Fan, S Li, R Wang, L Wang, J Ma*, T Jiang*, and W Ma*.Age-associated brain regions in gliomas: a volumetric analysis.J Neurooncol.2015.123(2).299-306.SCI

106. J Cai, W Zhang, P Yang, Y Wang, M Li, C Zhang, Z Wang, H Hu, Y Liu, Q Li, J Wen, B Sun, X Wang, T Jiang*. Identification of a 6-cytokine prognostic signature in patients with primary glioblastoma harboring m2 microglia/macrophage phenotype relevance. PLoS One.2015.10(5).e0126022.SCI

107. X Fan, Y Y Wang, C B Zhang, G You, M Y Li, L Wang*, and T Jiang*.Expression of RINT1 predicts seizure occurrence and outcomes in patients with low-grade gliomas.J Cancer Res ClinOncol.2015.141(4).729-34.SCI

108. Y Wang, X Fan, H Li, Z Lin, H Bao, S Li, L Wang, T Jiang, Y Fan*, and T Jiang*.Tumor border sharpness correlates with HLA-G expression in low-grade gliomas.J Neuroimmunol.2015.282.1-6.SCI

109. Y Wang, T Qian, G You, X Peng, C Chen, Y You, K Yao, C Wu, J Ma, Z Sha, S Wang*, and T Jiang*. Localizing seizure-susceptible brain regions associated with low-grade gliomas using voxel-based lesion-symptom mapping.Neuro Oncol.2015.17(2).282-8.SCI

110. Y Wang, K Wang, H Li, J Wang, L Wang, J Dai, T Jiang*, and J Ma*. Identifying the association of contrast enhancement with vascular endothelia growth factor expression in anaplastic gliomas: a volumetric magnetic resonance imaging analysis.PLoS One.2015.10(3).e0121380.SCI

111. Y Wang, T Zhang, S Li, X Fan, J Ma, L Wang*, and T Jiang*. Anatomical localization of isocitrate dehydrogenase 1 mutation: a voxel-based radiographic study of 146 low-grade gliomas.Eur J Neurol.2015.22(2).348-54.SCI

112. Z Wang, Z Zhang, Y Wang, G You*, and T Jiang*. Response to "Association of IDH1/2 mutation with preoperative seizure in low-grade gliomas: How strong is the evidence?.Epilepsy Res.2015.115.145-6.SCI

113. Z L Wang, C B Zhang, J Q Cai, Q B Li, Z Wang, and T Jiang*.Integrated analysis of genome-wide DNA methylation, gene expression and protein expression profiles in molecular subtypes of WHO II-IV gliomas. J ExpClin Cancer Res.2015.34(1).127.SCI

114. W Yan, Y Liu, P Yang, Z Wang, Y You*, and T Jiang*.MicroRNA profiling of Chinese primary glioblastoma reveals a temozolomide-chemoresistant subtype.Oncotarget.2015.6(13).11676-82.SCI

115. Y Y Wang, K Wang, S W Li, J F Wang, J Ma, T Jiang*, and J P Dai*. Patterns of Tumor Contrast Enhancement Predict the Prognosis of Anaplastic Gliomas with IDH1 Mutation.AJNR Am J Neuroradiol.2015.36(11).2023-9.SCI

116. Y Y Wang, T Zhang, S W Li, T Y Qian, X Fan, X X Peng, J Ma, L Wang*, and T Jiang*.Mapping p53 mutations in low-grade glioma: a voxel-based neuroimaging analysis.AJNR Am J Neuroradiol.2015.36(1).70-6.SCI

117. K Yao, X L Qi, X Mei, and T Jiang*.Gliosarcoma with primitive neuroectodermal, osseous, cartilage and adipocyte differentiation: a case report.Int J ClinExpPathol,.2015. 8(2).2079-84.SCI

118. C B Zhang, P Zhu, P Yang, J Q Cai, Z L Wang, Q B Li, Z S Bao, W Zhang, and T Jiang*. Identification of high risk anaplastic gliomas by a diagnostic and prognostic signature derived from mRNA expression profiling.Oncotarget.2015. 6(34). 36643-51.SCI

119. Z Zhong, Z Wang, Y Wang, G You*, and T Jiang*.IDH1/2 mutation is associated with seizure as an initial symptom in low-grade glioma: A report of 311 Chinese adult glioma patients.Epilepsy Res.2015.109.100-5.SCI

120. X Zhou, Y Ren, J Zhang, C Zhang, K Zhang, L Han, L Kong, J Wei, L Chen, J Yang, Q Wang, J Zhang, Y Yang, T Jiang*, M Li*, and C Kang*.HOTAIR is a therapeutic target in glioblastoma. Oncotarget.2015.6(10). 8353-65.SCI

121. Zhao-Shi Bao#, Hui-Min Chen#, Ming-Yu Yang#, Chuan-Bao Zhang, Kai Yu, WanLu Ye, Bo-Qiang Hu, Wei Yan, Wei Zhang, Johnny Akers, Valya Ramakrishnan, Jie Li, Bob Carter, Yan-Wei Liu, Hui-Min Hu, Zheng Wang, Ming-Yang Li, Kun Yao,XiaoGuang Qiu, Chun-Sheng Kang, XiaoDong Su*, Clark C. Chen*, Tao Jiang*.RNA-Seq of 272 gliomas revealed a novel, recurrent PTPRZ-MET fusion transcript in secondary glioblastomas.Genome Research.2014.24(11).1765-73.SCI

122. Z Bao, Y Feng, H Wang, C Zhang, L Sun, Z Yan, Q Liu, T Guo, M Li, X Yang, C Jiang, Q Zhang, and T Jiang.Integrated analysis using methylation and gene expression microarrays reveals PDE4C as a prognostic biomarker in human glioma.Oncol Rep.2014. 32(1).250-60.SCI

123. J Cai#, P Yang#, C Zhang#, W Zhang#, Y Liu, Z Bao, X Liu, W Du, H Wang, T Jiang*, and C Jiang*,.ATRX mRNA expression combined with IDH1/2 mutational status and Ki-67 expression refines the molecular classification of astrocytic tumors: evidence from the whole transcriptome sequencing of 169 samples samples.Oncotarget.2014.5(9).2551-61.SCI

124. Z S Bao#, G You, W B Li, and T Jiang*.A single aspergillus fumigatus intracranial abscess in an immunocompetent patient with parietal lobe tumorectomy.World J SurgOncol.2014.12(1).181.SCI

125. T Guo#, Y Feng, Q Liu, X Yang, T Jiang*, Y Chen*, and Q Zhang*.MicroRNA-320a suppresses in GBM patients and modulates glioma cell functions by targeting IGF-1R. TumourBiol.2014.35(11).11269-75.SCI

126. Y Liu#, H Hu#, K Wang, C Zhang, Y Wang, K Yao, P Yang, L Han, C Kang, W Zhang*, and T Jiang*.Multidimensional analysis of gene expression reveals TGFB1I1-induced EMT contributes to malignant progression of astrocytomas.Oncotarget.2014.5(24).12593-606.SCI

127. Z S Bao#, M Y Li#, J Y Wang, C B Zhang, H J Wang, W Yan, Y W Liu, W Zhang, L Chen, and T Jiang*.Prognostic value of a nine-gene signature in glioma patients based on mRNA expression profiling.CNS NeurosciTher.2014.20(2).112-8.SCI

128. Y Feng#, Z Wang#, Z Bao, W Yan, G You, Y Wang, H Hu, W Zhang, Q Zhang, and T Jiang*.SOCS3 promoter hypermethylation is a favorable prognosticator and a novel indicator for G-CIMP-positive GBM patients. PLoS One.2014.9(3).e91829.SCI

129. Y Sun#, W Zhang#, D Chen, Y Lv, J Zheng, H Lilljebjorn, L Ran, Z Bao, C Soneson, H O Sjogren, L G Salford, J Ji, P J French, T Fioretos, T Jiang*, and X Fan*.A glioma classification scheme based on coexpression modules of EGFR and PDGFRA.Proc Natl AcadSci .2014.111(9).3538-43.SCI

130. Y Wang#, X Chen, Z Zhang, S Li, B Chen, C Wu, L Wang, X Zhang, J Wang, L Chen, and T Jiang*.Comparison of the clinical efficacy of temozolomide (TMZ) versus nimustine (ACNU)-based chemotherapy in newly diagnosed glioblastoma.Neurosurg Rev.2014.37(1).73-8.SCI

131. P Yang, G You, W Zhang, Y Wang, Y Wang, K Yao, and T Jiang*.Correlation of preoperative seizures with clinicopathological factors and prognosis in anaplastic gliomas: a report of 198 patients from China.seizure.2014. 23(10).844-51.SCI

132. Y Wang, X Fan, C Zhang, T Zhang, X Peng, T Qian, J Ma, L Wang, S Li*, and T Jiang*,.Identifying radiographic specificity for phosphatase and tensin homolog and epidermal growth factor receptor changes: a quantitative analysis of glioblastomas.Neuroradiology.2014. 56(12).1113-20.SCI

133. C B Zhang, Z S Bao, H J Wang, W Yan, Y W Liu, M Y Li, W Zhang, L Chen*, and T Jiang*.Correlation of IDH1/2 mutation with clinicopathologic factors and prognosis in anaplastic gliomas: a report of 203 patients from China. J Cancer Res ClinOncol,.2014.140(1).45-51.SCI

134. T Zhang, Y Wang, X Fan, J Ma, S Li, T Jiang*, and L Wang*.Anatomical localization of p53 mutated tumors: A radiographic study of human glioblastomas.J NeurolSci.2014.346(1-2).94-8.SCI

135. Y Wang, X Fan, C Zhang, T Zhang, X Peng, S Li, L Wang, J Ma, and T Jiang.Anatomical specificity of O6-methylguanine DNA methyltransferase protein expression in glioblastomas.J Neurooncol.2014. 120(2).331-7.SCI

136. Y Wang, X Fan, C Zhang, T Zhang, X Peng, T Qian, J Ma, L Wang, S Li, and T Jiang.Identifying radiographic specificity for phosphatase and tensin homolog and epidermal growth factor receptor changes: a quantitative analysis of glioblastomas.Neuroradiology.2014.56(12).1113-20.SCI

137. W Yan, R Li, Y Liu, P Yang, Z Wang, C Zhang, Z Bao, W Zhang, Y You, and T Jiang.MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis.Oncotarget.2014.5(24).12908-15.SCI

138. Zhao P, Zhao L, Zou P, Lu A, Liu N, Yan W, Kang C, Fu Z, You Y, Jiang T*.Genetic oxidative stress variants and glioma risk in a Chinese population: a hospital-based case--control study.BMC Cancer.2013.12(1).617.SCI

139. Chen YD, Zhang X, Qiu XG, Li J, Yuan Q, Jiang T*, Yang M.Functional FEN1 genetic variants and haplotypes are associated with glioma risk.J Neurooncol.2013.111(2).145-51.SCI

140. Wang Y, Jiang T*.Understanding High Grade Glioma: Molecular Mechanism, Therapy and Comprehensive Management.Cancer Lett.2013.331(2).139-46.SCI

141. Yan ZH, Bao ZS, Yan W, Liu YW, Zhang CB, Wang HJ, Feng Y, Wang YZ, Zhang W, You G, Zhang QG, Jiang T*.Upregulation of DLX2 confers a poor prognosis in glioblastoma patients by inducing a proliferative phenotype.Curr Mol Med.2013.13(3).438-45.SCI

142. Zhang JX, Zhang J, Yan W, Wang YY, Han L, Yue X, Liu N, You YP, Jiang T*, Pu PY, Kang CS.Unique genome-wide map of TCF4and STAT3 targets using ChIP-seq reveals their association with new molecular subtypes of glioblastoma.Neuro-Oncology.2013.15(3).279-89.SCI

143. Zhang W, Yan W, You G, Bao Z, Wang Y, Liu Y, You Y, Jiang T*.Genome-wide DNA methylation profiling identifies ALDH1A3 promoter methylation as a prognostic predictor in G-CIMP- primary glioblastoma.Cancer Lett.2013.328(1).120-5.SCI

144. Li S, Yan C, Huang L, Qiu X, Wang Z, Jiang T*.Molecular prognostic factors of anaplastic oligodendroglial tumors and its relationship: a single institutional review of 77 patients from China.Neuro-Oncology.2012.14(1).109-116.SCI

145. Yan W, Zhang W, You G, Bao Z, Wang Y, Liu Y, Kang C, You Y, Wang L, Jiang T*.Correlation of IDH1 mutation with clinicopathologic factors and prognosis in primary glioblastoma: a single institutional review of 118 patients from China.PLoS One.2012.7(1).e30339.SCI

146. Wang Y, Li S, Chen L, You G, Bao Z, Yan W, Shi Z, Chen Y, Yao K, Zhang W, Kang C, Jiang T*.Glioblastoma with oligodendroglioma component: distinct clinical behavior, genetic alterations and outcome.Neuro-Oncology.2012.14(4).518-25.SCI

147. You G, Sha ZY, Yan W, Zhang W, Wang YZ, Li SW, Sang L, Wang Z, Li GL, Li SW, Song YJ, Kang CS, Jiang T*.Seizure characteristics and outcomes in 508 Chinese adult patients undergoing primary resection of low-grade gliomas: a clinicopathological study. Neuro-Oncology.2012.14(2).230-41.SCI

148. Chen Q, Chen XZ, Wang JM, Li SW, Jiang T*, Dai JP*.Intracranial Meningeal Hemangiopericytomas in Children and Adolescents: CT and MR Imaging Findings.AJNR Am J Neuroradiol.2012.33(1).195-9.SCI

149. Zhang W, Zhang J, Hoadley K, Kushwaha D, Ramakrishnan V, Li S, Kang C, You Y, Jiang C, Song SW, Jiang T*, Chen CC.miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expression.Neuro Oncol.2012.14(6).712-9.SCI

150. Kai Tang,Tao Jiang*.Clinical correlation of MGMT protein expression and promoter methylation in Chinese glioblastoma patients.Med Oncol.2011.in press.-.SCI

151. Lei Huang,Gan You,Tao Jiang* .Correlation between tumor-related seizures and molecular genetic profile in 103 Chinese patients with low-grade gliomas: A preliminary study.Journal of the Neurological Sciences.2011.302.63–67.SCI

152. Li WB, Tang K, Zhang W, Yan W, You G, Li SW, Zhang L, Huang YJ, Jiang T*.Relationship between magnetic resonance imaging and molecular pathology in patients with glioblastoma multiforme.Chinese Medical Journal.2011.124(17).2589-2592.SCI

153. Yan W, Zhang W, Jiang T*.Oncogene addiction in gliomas: implications for molecular targeted therapy.Journal of Experimental & Clinical Cancer Research .2011.30(58).1-5.SCI

154. Jiang T*, Tang GF, Lin Y, Peng XX, Zhang X, Zhai XW, Peng X, Yang JQ, Huang HE, Wu NF, Chen XJ, Xing HX, Su TY, Wang ZC.Prevalence estimates for primary brain tumors in China: a multi-center cross-sectional study.Chinese Medical Journal.2011.124(17).2578-2583.SCI

155. Kai Huang,Tao Jiang*.MicroRNA roles in beta-catenin pathway.Molecular Cancer.2010.252.1-12.SCI

156. Lei Han1,Tao Jiang*.Inactivation of PI3K/AKT signaling inhibits glioma cell growth through modulation of β-catenin-mediated transcription.Brain Research.2010.1366.9-17.SCI

157. Xiao Yue,Tao Jiang*.Interruption of β-catenin supresses the EGFR pathway by blocking multiple oncogenic targets in human glioma cells.Brain Research.2010.1366.27-37.SCI

158. 王永志，江濤*.雙語腦語言轉換和語言代表區的術中直接電刺激研究.中國微侵襲神經外科雜.2009.14(1).6-9.核心期刊

159. 吳陳興，江濤*.累及Broca區低級別膠質瘤的BOLD-fMRI及語言功能區的可塑性研究.中國微侵襲神經外科雜.2009.14(1).10-13.核心期刊

160. 江濤.大腦膠質瘤的分子病理分型與化療.中國微侵襲神經外科雜.2009.14(1).1-2.核心期刊

161. 儀曉立，江濤*.功能區膠質瘤手術前后語言功能皮質的變化.中國微侵襲神經外科雜.2009.14(1).3-5.核心期刊

162. 張忠，江濤*.術中功能定位切除輔助運動區低級別膠質瘤 .中華神經外科雜志.2008.24（1）.35-37.核心期刊

163. 宗淼，江濤*.少枝膠質細胞瘤的動態生長變化.中華神經外科雜志 .2008.24（5）.363-365.核心期刊

164. 周開甲,江濤*.血漿IGFBP-2在腦膠質母細胞瘤治療前后變化.中華神經外科雜志 .2008.24（7）.490-492.核心期刊

165. 陳緒珠，江濤*.低級別腦膠質瘤的手術時機：18例動態影像學觀察.中國微侵襲神經外科雜.2008.13(6).120-122.核心期刊

166. 陳寶師，江濤*.抗血管生成靶向藥物治療惡性膠質瘤的臨床研究.中國現代神經疾病雜志.2008.8(5).432-436.核心期刊

167. 周開甲，江濤*.IGFBP-2在高級別腦膠質瘤中作用的研究進展 .中國微侵襲神經外科雜志.2007.12(6).285－288.核心期刊

168. 周開甲，江濤*.膠質細胞瘤血漿IGFBP-2濃度的動態監測及其臨床意義 .中國微侵襲神經外科雜志.2007.12(11).510-513.核心期刊

169. 江濤.腦膠質瘤的分子靶向治療 .中華神經外科雜志.2007.23（9）.641-642.核心期刊

170. 張忠，江濤*.喚醒麻醉和術中功能定位切除語言區膠質瘤 .中華神經外科雜志.2007.23（9）.643-645.核心期刊

171. 張忠，江濤*.術中實時超聲在腦功能區膠質瘤手術中的應用價值 .中國微侵襲神經外科雜志.2007.12(11).497-498.核心期刊

172. 謝堅，江濤*.應用腦功能磁共振成像及彌散張量成像技術輔助切除腦運動區皮層深部區域的膠質瘤.中華外科雜志.2006.44（9）.1283-1284.核心期刊

173. Yiwen Cao,Chuanlu Jiang,Tao Jiang*.Molecular Cloning and Preliminary Analysis of a Fragile Site Associated Gene .Biomedical and Enviromental Sciences.2006.19.392-398.SCI

174. Tao Jiang*.Role of 3T High Field BOLD fMRI in Brain Cortical Mapping for Glioma Involving Eloquent Areas.MIRA.2006.LNCS 4091.92-99.SCI

175. 江濤*,高之憲.臨床研究生帶教體會——“受之與漁”,而非“受之與魚”.首都醫科大學學報.2006.S1.226-228.核心期刊

176. 宗淼，江濤*.綜合治療大腦半球膠質瘤的臨床研究.中華外科雜志.2006.44（9）.1282-1283.核心期刊

177. 李子孝，江濤*.功能和纖維成像在腦功能區膠質瘤中的應用.中華外科雜志.2006.44（9）.1275-1279.核心期刊

178. 江濤.膠質瘤的分子病理分類和靶向治療的研究.中華外科雜志.2006.44（9）.1292-1294.核心期刊

179. 江濤*, 陳新中 ,謝堅.功能區膠質瘤的術中直接電刺激判斷核心手術技術.中國微侵襲神經外科雜志.2005.10（4）.148-150.核心期刊

180. 江濤* , 于春江.巖-斜區腦膜瘤顯微外科治療進展.中國微侵襲神經外科雜志.2001.6(2).126-127 .核心期刊

181. 江濤 *,于春江 ,郭爾安 ,關樹森.大型前庭神經雪旺細胞瘤與面神經病理解剖關系的臨床研究.中華醫學雜志.2001.81(9).536-537.核心期刊

182. 江濤*, 于春江, 郭爾安.聽神經瘤枕下乙狀竇后入路開顱技術的改進臨床研究.中國微侵襲神經外科雜志.2001.6(1).19-21.核心期刊

183. 江濤 *,于春江, 王忠誠.聽神經瘤術后聽力保留三個問題.中國微侵襲神經外科雜志.2001.6(1).3-5.核心期刊

184. 江濤 * ,王忠誠 ,于春江.聽神經瘤聽力保留的顯微解剖學研究.中國微侵襲神經外科雜志.2001.6(1).38-42.核心期刊

185. 江濤* ,王忠誠 ,于春江, 陳菲 ,王風梅.經巖骨乙狀竇前入路-骨迷路與面神經管保護的解剖與臨床研究.中國微侵襲神經外科雜志.2000.5（2）.65-68.核心期刊

186. 江濤* , 丁艷玲 , 于春江.經巖骨側方入路手術切除斜坡表皮樣囊腫.中華醫學雜志.2000.80（3）.200-201.核心期刊

187. 江濤 *,于春江 ,張亞卓, 王忠誠.腦干腹側方解剖間隙觀察與研究.中華神經外科雜志.2000.1（16）.24-28.核心期刊

188. 江濤* , 王忠誠 ,于春江 ,張保中, 張紀.海綿竇相關顯微外科相關三角解剖學研究.中華神經外科雜.1999.15（1）.45-49.核心期刊

189. 江濤* ,王忠誠 ,于春江, 劉吉祥, 陳菲 .單側枕下乙狀竇后入路磨開內耳道后壁解剖學研究與骨迷路保護.中華神經外科雜志.1999.15（4）.196-199.核心期刊

190. 江濤 *, 戴欽舜, 劉恩重 , 趙立富 , 李昌盛.大腦中動脈間斷阻斷安全時間的實驗研究.中國微侵襲神經外科雜志.1998.3（2）.112-114.核心期刊

191. 江濤* , 戴黎萌 , 戴欽舜.白細胞，單核細胞與缺血復流后二次腦損傷.基礎醫學與臨床.1998.18（2）.12-14.核心期刊

192. 江濤* , 劉相珍, 戴欽舜 ,陳會榮 , 黃正松.腦血管畸形栓塞后手術切除.中華神經外科雜志.1998.14（4）.241-242.核心期刊

193. 江濤*, 于春江, 王忠誠.CPA腫瘤術后聽力保存若干問題.國外醫學神經病學神經外科學分冊.1998.25（4）.197-201.核心期刊

194. 江濤* ， 王忠誠 ，于春江， 陳菲 ，王風梅.遠外側經髁入路巨顯微解剖學研究.中華醫學雜志.1998.78（6）.448-451.核心期刊

195. 江濤* , 戴欽舜 , 劉恩重 , 趙立富 , 李昌盛.腦缺血-再灌注損傷中興奮氨基酸的變化.中華神經外科雜志.1997.13（4）.219-221.核心期刊

196. 江濤* , 黃正松 , 戴欽舜 ,劉恩重.選擇性、超選擇性血管內溶栓治療閉塞性腦血管病.哈爾濱醫科大學學報.1995.29（3）.268-269.核心期刊

197. 江濤* , 黃正松 ,戴欽舜 , 劉恩重.不用開顱的腦缺血-再灌注模型的制備.國外醫學腦血管疾病分冊.1994.2（13）.38-39.核心期刊

主編或副主編的著作/譯著

1. 《腦膠質瘤中國腫瘤整合診治指南》,主編,天津出版傳媒集團,2022

2. 《腦膠質瘤診療新進展》,主編,中國協和醫科大學出版社,2021

3. 《神經與精神疾病》,主編,人民衛生出版社,2021

4. 《中國腦膠質瘤臨床管理指南2020》,主編,人民衛生出版社,2020

5. 《顱腦腫瘤外科學（第2版）》,主編,人民衛生出版社,2020

6. 《腦白質纖維網絡3D智能解剖圖譜》,主編,人民衛生出版社,2020

7. 《膠質瘤臨床醫生使用手冊》,主編,復旦大學出版社,201608

8. 《腦膠質瘤的臨床治療技術與進展》,主編,人民衛生出版社,201109

9. 《腦腫瘤化學治療》,主編,人民衛生出版社,200809

10. 《腦膠質瘤》,主編,人民衛生出版社,200704

11. 《海綿竇：顯微解剖、手術入路、神經影像》,主編,中國協和醫科大學出版社,200601

12. 《腦室外科手術學》,主編,中國協和醫科大學出版社,200110

重要獎項

1. 腦膠質瘤惡性進展關鍵驅動因素的發現及全新小分子抑制劑的開發應用 中國發明協會發明創業獎一等獎 一等獎 2022

2. 神經外科 第十四屆光華工程科技獎 一等獎 2022

3. 首都醫科大學附屬北京天壇醫院腦膠質瘤精準診療創新團隊 北京市工人先鋒號 2022

4. MET小分子抑制劑在中樞神經系統腫瘤靶向治療中的應用研究 中關村前沿科技創新大賽 冠軍 2021

5. “改變實踐的年度中國原創研究”十大原創研究領銜者 2020

6. - 北京學者 市級人才 201909

7. 腦膠質瘤診療關鍵技術創新與推廣應用 國家科學技術進步獎 二等獎 201712

8. 北京市“高創計劃”領軍人才 市級人才 2015

9. 北京市先進工作者 市級人才 2015

10. 腦膠質瘤診療技術創新研究與臨床應用 中國抗癌協會科技獎 二等獎 201409

11. 科技北京百名領軍人才 科技北京百名領軍人才 省部級 201212

12. 教育部科技進步獎 教育部科技進步一等獎 省部級 201212

13. 2009年北京市新世紀百千萬人才工程 市十級人才 200908

14. 大腦功能區病變手術新技術研究 廣東省科技進步獎 二等獎 200908

15. 2008年北京市新世紀百千萬人才工程 市級人選 200810

16. 2008年中國醫師協會神經外科醫師分會分會杰出青年神經外科醫師獎獲得者 杰出青年神經外科醫師獎 200807

17. 王忠誠中國神經外科醫師年度獎 2007年度青年獎 200803

18. 腦深部腫瘤顯微手術及相關基礎研究 中華醫學科技獎 二等獎 200612

19. 2005年北京市新世紀百千萬人才工程 市百級人才 200508

20. 前庭神經雪旺氏細胞（聽神經瘤）顯微外科治療 北京市科學技術進步獎 三等獎 200212

21. 神經外科手術中誘發電位監測的研究 北京市科學技術進步獎 三等獎 200212

22. 顱底外科手術入路顯微解剖與臨床研究 北京市科學技術進步獎 三等獎 200012

23. 北京市衛生局第七屆青年科技論文 優秀獎 200004

24. 衛生部國際交流中心-日本第一制藥醫藥學獎學金 醫藥學獎學金 第一 1995